PREPARE - Getting the Conversation Started: The Latest Data and Guidelines on the Integration of Cognitive Health Screening into Clinical Practice

IN PARTNERSHIP WITH

Saturday, November 15, 2025

6:00 AM – 7:30 AM PT simulcast
7:00 AM – 8:30 AM MT
8:00 AM – 9:30 AM CT
9:00 AM – 10:30 AM ET

EARN UP TO 1.5 CME/CNE CREDITS!

Program Overview

The PREPARE Summit program is an interactive, case-based educational series designed to help clinicians identify, evaluate, and manage early cognitive decline in primary care settings. Led by experts in neurology, geriatrics, and primary care, this program emphasizes the use of validated screening tools, clinical signs and symptoms, and emerging biomarkers to differentiate normal aging from early cognitive impairment. It aims to empower primary care providers with the knowledge and tools to adopt updated guidelines, initiate meaningful discussions with patients and caregivers, and coordinate multidisciplinary care to promote early detection and cognitive preservation, optimize brain health, and manage cognitive decline effectively.

Target Audience

This activity is tailored to meet the educational needs of healthcare practitioners involved in managing patients with cognitive health concerns. The primary audience includes primary care clinicians and general practitioners (MDs/DOs/NPs/PAs), general neurologists, and geriatricians, with a secondary audience of psychiatrists and OB-GYNs.

Learning Objectives

Upon the completion of this program, attendees should be able to:

• Appraise cognitive health screening best practices to differentiate normal aging from early cognitive decline using validated tests, while offering appropriate management strategies and specialist referral
• Justify the use of clinical signs and symptoms, as well as biomarkers, to detect neuropathological changes in cognitive health conditions
• Model the integration of new data and guideline recommendations for cognitive health assessments into clinical practice
• Initiate conversations about cognitive health and cognitive preservation through patient and caregiver discussions and interdisciplinary communication across the cognitive health team

Joint Accreditation Statement

In support of improving patient care, Med Learning Group is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

Physician Credit Designation Statement

Med Learning Group designates this live activity for a maximum of 1.5 AMA PRA Category 1 Credits^TM. Physicians should claim only the credit commensurate with the extent of their participation in the live activity.

Nurses (ANCC) Credit Designation

Med Learning Group designates this activity for a maximum of 1.5 ANCC contact hours.

ACCME Innovation Partner

Med Learning Group (MLG) is proud to be recognized as an ACCME Innovation Partner, leading the way in simplifying CME for physicians. As an Innovation Partner, MLG will be working with the ACCME by submitting credits directly to CME Passport.

ACCME Innovation Partner Disclaimer

Upon your acceptance in the evaluation and completion of this CME activity, Med Learning Group will share your completion information and certain personal details (eg., name, National Provider Identifier, birthdate MM/DD) with the ACCME for inclusion in your CME Passport transcript and, as applicable, reporting to certifying, licensing, or other regulatory authorities you specify.

Disclosure Policy Statement

In accordance with the Accreditation Council for Continuing Medical Education (ACCME) Standards for Integrity and Independence in Accredited Continuing Education, educational programs sponsored by Med Learning Group must demonstrate balance, independence, objectivity, and scientific rigor. All faculty, authors, editors, staff, and planning committee members participating in an MLG-sponsored activity are required to disclose any relevant financial interest or other relationship with the manufacturer(s) of any commercial product(s) and/or provider(s) of commercial services that are discussed in an educational activity.

Disclosure Of Unlabeled Use

Med Learning Group requires that faculty participating in any CE activity disclose to the audience when discussing any unlabeled or investigational use of any commercial product or device not yet approved for use in the United States. During this lecture, the faculty may mention the use of medications for both FDA-approved and non-approved indications.

Method of Participation

There are no fees for participating and receiving CE credit for this activity. In order to obtain your certificate for the mentioned accreditation, participants need to successfully complete the associated pre/post activities and evaluation. Your certificate will be provided as a downloadable file.

Disclaimer

Med Learning Group makes every effort to develop CE activities that are science based. This activity is designed for educational purposes. Participants have a responsibility to use this information to enhance their professional development in an effort to improve patient outcomes. Conclusions drawn by the participants should be derived from careful consideration of all available scientific information. The participant should use his/her clinical judgment, knowledge, experience, and diagnostic decision-making expertise before applying any information, whether provided here or by others, for any professional use.

For CE questions, please contact Med Learning Group at info@medlearninggroup.com

Contact this CE provider at Med Learning Group for privacy and confidentiality policy statement information at https://www.medlearninggroup.com/privacy-policy/

Release date: November 15, 2025
Expiration date: November 15, 2026
Estimated time to completion: 1.5 hours